FDA clears CAP-003 Parkinson's gene therapy to be tested in trials
The FDA has cleared CAP-003, a gene therapy for Parkinson’s associated with GBA mutations, to be tested in clinical trials.| Parkinson's News Today
The FDA has cleared CAP-003, a gene therapy for Parkinson’s associated with GBA mutations, to be tested in clinical trials.| Parkinson's News Today
Lila is a Science Writer at BioNews. She completed her PhD in neuroscience at the University of Washington, where she studied how the natural flexibility of the human brain can be used to promote recovery after injury. Previously, she has written about science for The Dallas Morning News and the...| Parkinson's News Today
Parkinson's patients in a pilot study at Texas A&M say they enjoy equine-assisted therapy, and researchers hope to prove it's effective.| Parkinson's News Today
Category archive page for News.| Parkinson's News Today
